R. Davidson

发表

Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.

J. Melo, J. Goldman, S. O’Brien, 1994, Leukemia.

Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

J. Goldman, D. Nguyen, M. Gordon, 1998, The Journal of clinical investigation.

Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics

Jl Lewis, B. Zheng, M. Gordon, 2001, Bone Marrow Transplantation.

Rapamycin for GVHD prophylaxis - potential for severe myelotoxicity

M. Gordon, S. Marley, R. Davidson, 2001, Bone Marrow Transplantation.

REVIEW Cell biology of CML cells

D. Nguyen, M. Gordon, J. Lewis, 1999 .

A two‐color BCR–ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia

A. Chase, D. Nguyen, M. Gordon, 1998, Genes, chromosomes & cancer.

Cell biology of CML cells

Jl Lewis, D. Nguyen, M. Gordon, 1999, Leukemia.

The tyrosine kinase inhibitor STI571, like interferon-α, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia

M. Deininger, J. Goldman, S. Marley, 2000 .

numbers engraftment and evidence for long-lasting reduction in stem cell allogeneic bone marrow transplantation: relationship with rate of Quantitation of mafosfamide-resistant pre-colony-forming units in

J. Goldman, A. Spencer, M. Kirkland, 2011 .

Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers.

J. Goldman, A. Spencer, M. Kirkland, 1996, Blood.

Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation

M. Gordon, J. Goldman, S. Marley, 1999, Bone Marrow Transplantation.

Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM

M. Gordon, J. Goldman, S. Marley, 2000, Leukemia.

BCR-ABL antisense purging in chronic myeloid leukaemia

J. Goldman, N. Cross, S. O’Brien, 1993, The Lancet.

Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemia

J. Goldman, S. Marley, M. Gordon, 2002, British journal of haematology.

Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34.

J. Goldman, F. Grand, D. Nguyen, 2000, The hematology journal : the official journal of the European Haematology Association.

The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.

M. Deininger, J. Goldman, M. Gordon, 2000, Experimental hematology.

Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children

Goldman, Roberts, S. Marley, 1999, British journal of haematology.